CDW52-specific antibody for treatment of multiple sclerosis
US6120766A · kind A · utility
90Cited by
3References
6Claims
0Family size
Inventors
Key dates
| Filing date | Jun 22, 1994 |
| Grant date | Sep 19, 2000 |
| Priority date | — |
| Expiry date | Jun 22, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of an antibody recognizing the Cdw52 antigen in the treatment of multiple sclerosis. Preferably, the antibody is the humanized antibody in the humanized antibody CAMPATH-1H.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.